Manhattan Gold Corporation Limited (ASX: MHC)
Investment thesis: Manhattan offers high‑risk, high‑reward exposure to a district‑scale, underexplored gold and polymetallic system in Nunavut. With a documented ~285koz historical endowment, 2025 high‑grade surface confirmation and a fully funded maiden RC programme now underway, the stock provides asymmetric upside to discovery outcomes while remaining speculative.
Hook Lake sits in the Rankin–Ennadai greenstone belt, a tier‑one address proximate to multi‑million ounce camps, and combines a substantial legacy database with fresh, selective surface assays that materially expand the regional target set.
Documented historical footprint: Jaws hosts a non‑JORC historical estimate of ~3.39Mt @ 2.38g/t Au (~285koz) supported by ~10,620m of legacy drilling.
High‑grade modern confirmation: 2025 surface assays include up to 173.5g/t Au (Defender), 16.75g/t Au (Quantum) and 2,660g/t Ag (Lotus), indicating broad polymetallic potential.
Drilling & de‑risking underway: Fully funded 4,000m RC programme commenced 23 June 2026 (contracted to Northspan); first modern assays expected mid‑2026; regulatory permits and local approvals in place.
Value asymmetry: At an enterprise value of ~A$11.2m, MHC offers leverage to early discovery catalysts versus peers, though geological and execution risk remain high.
Recommendation: Speculative Buy, Price Target A$0.082 (12‑month horizon). Read the full report for the complete analysis.